Palisade Bio (PALI) Total Current Liabilities (2010 - 2026)

Palisade Bio (PALI) has 17 years of Total Current Liabilities data on file, last reported at $5.6 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 102.38% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $5.6 million, a 102.38% increase from a year earlier, with the FY2025 full-year figure at $4.6 million, up 43.26% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $5.6 million, up from $4.6 million in the prior quarter.
• Over the last five years, Total Current Liabilities for PALI reached as high as $5.6 million in Q1 2026 and fell as low as $1.3 million in Q1 2023.
• Historically, Total Current Liabilities has averaged $3.0 million across 5 years, with a median of $2.8 million in 2024.
• Across the five-year window, Total Current Liabilities slipped 29.45% in 2023 and jumped 102.38% in 2026, its largest moves.
• Year by year, Total Current Liabilities stood at $3.0 million in 2022, then fell by 14.14% to $2.6 million in 2023, then gained by 25.14% to $3.2 million in 2024, then jumped by 43.26% to $4.6 million in 2025, then rose by 21.23% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $5.6 million in Q1 2026, $4.6 million in Q4 2025, and $3.5 million in Q3 2025.